Status:
COMPLETED
Incidence of Postoperative Residual Neuromuscular Blockade in Portugal
Lead Sponsor:
Centro Hospitalar do Porto
Conditions:
Residual Neuromuscular Blockade
Residual Paralysis, Post-Anesthesia
Eligibility:
All Genders
18+ years
Brief Summary
This is an epidemiological multicenter, observational, prospective study, designed to determine the incidence of postoperative residual neuromuscular blockade - defined by a TOF (train-of-four) ratio ...
Detailed Description
This is a multicenter, observational/non-interventional study involving adult patients undergoing different types of elective surgical procedures requiring general anesthesia with neuromuscular blocki...
Eligibility Criteria
Inclusion
- 18 years of age or older;
- Informed consent signed;
- Admission for elective surgery;
- Administration of non-depolarizing NMBAs during surgery
Exclusion
- Admission for emergency surgery;
- Reoperation on the same hospital admission;
- More than 10 minutes elapsed between extubation and neuromuscular block monitoring at PACU
Key Trial Info
Start Date :
June 18 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2019
Estimated Enrollment :
366 Patients enrolled
Trial Details
Trial ID
NCT03417804
Start Date
June 18 2018
End Date
November 1 2019
Last Update
July 6 2021
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Prof. Fernando Fonseca, EPE
Amadora, Portugal, 2720-276
2
Centro Hospitalar Baixo Vouga
Aveiro, Portugal
3
Centro Hospitalar Universitário de Coimbra
Coimbra, Portugal
4
Centro Hospitalar Lisboa Norte
Lisbon, Portugal